0QEN Stock Overview
Coala-Life Group AB (publ) operates as a medical device company.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Coala-Life Group AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.029 |
| 52 Week High | €0.11 |
| 52 Week Low | €0.029 |
| Beta | 1.02 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -99.86% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0QEN | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | 0% | -2.4% | 0.6% |
| 1Y | n/a | -12.9% | 8.3% |
Return vs Industry: Insufficient data to determine how 0QEN performed against the UK Medical Equipment industry.
Return vs Market: Insufficient data to determine how 0QEN performed against the UK Market.
Price Volatility
| 0QEN volatility | |
|---|---|
| 0QEN Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 6.2% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 11.2% |
| 10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: 0QEN's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine 0QEN's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 89 | Dan Pitulia | www.coalalife.com |
Coala-Life Group AB (publ) operates as a medical device company. The company develops medical innovations that enable long-term monitoring of patients in daily life, which supports diagnosis of heart and lungs and improve clinical outcomes. Its products offer healthcare providers diagnostic support by the ability to follow patient’s in everyday life.
Coala-Life Group AB (publ) Fundamentals Summary
| 0QEN fundamental statistics | |
|---|---|
| Market cap | SEK 283.57m |
| Earnings (TTM) | -SEK 147.62m |
| Revenue (TTM) | SEK 49.07m |
0.0x
P/S Ratio0.0x
P/E RatioIs 0QEN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0QEN income statement (TTM) | |
|---|---|
| Revenue | SEK 49.07m |
| Cost of Revenue | SEK 60.62m |
| Gross Profit | -SEK 11.55m |
| Other Expenses | SEK 136.07m |
| Earnings | -SEK 147.62m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.10 |
| Gross Margin | -23.55% |
| Net Profit Margin | -300.87% |
| Debt/Equity Ratio | 0% |
How did 0QEN perform over the long term?
See historical performance and comparison